135 related articles for article (PubMed ID: 2531841)
21. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. II. Identification and properties of complement receptor type 1 (CR1).
Kinoshita T; Lavoie S; Nussenzweig V
J Immunol; 1985 Apr; 134(4):2564-70. PubMed ID: 3156184
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
23. Active site of C3a anaphylatoxin: contributions of the lipophilic and orienting residues.
Unson CG; Erickson BW; Hugli TE
Biochemistry; 1984 Feb; 23(4):585-9. PubMed ID: 6608957
[TBL] [Abstract][Full Text] [Related]
24. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
Medicus RG; Melamed J; Arnaout MA
Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
[TBL] [Abstract][Full Text] [Related]
25. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b.
Mold C; Kingzette M; Gewurz H
J Immunol; 1984 Aug; 133(2):882-5. PubMed ID: 6234363
[TBL] [Abstract][Full Text] [Related]
26. Inactivation of C3a by a monocarboxypeptidase present in culture supernatants of stimulated guinea pig peritoneal macrophages.
Kreuzpaintner G; Damerau B; Zimmermann B; Plummer TH; Brade V
J Immunol; 1986 May; 136(9):3384-9. PubMed ID: 3485689
[TBL] [Abstract][Full Text] [Related]
27. Amino acid sequence of bovine brain derived class 1 heparin-binding growth factor.
Strydom DJ; Harper JW; Lobb RR
Biochemistry; 1986 Mar; 25(5):945-51. PubMed ID: 2421762
[TBL] [Abstract][Full Text] [Related]
28. C4a: the third anaphylatoxin of the human complement system.
Gorski JP; Hugli TE; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5299-302. PubMed ID: 291947
[TBL] [Abstract][Full Text] [Related]
29. Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum.
Del Tordello E; Vacca I; Ram S; Rappuoli R; Serruto D
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):427-32. PubMed ID: 24367091
[TBL] [Abstract][Full Text] [Related]
30. Structural characterization of factor I mediated cleavage of the third component of complement.
Davis AE; Harrison RA
Biochemistry; 1982 Nov; 21(23):5745-9. PubMed ID: 6217832
[No Abstract] [Full Text] [Related]
31. Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.
Sahu A; Kay BK; Lambris JD
J Immunol; 1996 Jul; 157(2):884-91. PubMed ID: 8752942
[TBL] [Abstract][Full Text] [Related]
32. Purification and partial characterization of human and porcine C3a anaphylatoxin.
Hugli TE; Vallota EH; Müller-Eberhard HJ
J Biol Chem; 1975 Feb; 250(4):1472-8. PubMed ID: 803505
[TBL] [Abstract][Full Text] [Related]
33. Amino acid sequence of a specific antigenic peptide of protein B23.
Chan PK; Chan WY; Yung BY; Cook RG; Aldrich MB; Ku D; Goldknopf IL; Busch H
J Biol Chem; 1986 Oct; 261(30):14335-41. PubMed ID: 2429957
[TBL] [Abstract][Full Text] [Related]
34. Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom Factor.
Hew BE; Wehrhahn D; Fritzinger DC; Vogel CW
Toxicon; 2012 Sep; 60(4):632-47. PubMed ID: 22609532
[TBL] [Abstract][Full Text] [Related]
35. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
36. The primary structure of iron-superoxide dismutase from Photobacterium leiognathi.
Barra D; Schininà ME; Bannister WH; Bannister JV; Bossa F
J Biol Chem; 1987 Jan; 262(3):1001-9. PubMed ID: 3542995
[TBL] [Abstract][Full Text] [Related]
37. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
38. Isolation and characterization of cholecystokinin-58 (CCK-58) from porcine brain.
Tatemoto K; Jörnvall H; Siimesmaa S; Halldén G; Mutt V
FEBS Lett; 1984 Sep; 174(2):289-93. PubMed ID: 6468664
[TBL] [Abstract][Full Text] [Related]
39. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
Kozono H; Kinoshita T; Kim YU; Takata-Kozono Y; Tsunasawa S; Sakiyama F; Takeda J; Hong K; Inoue K
J Biol Chem; 1990 Aug; 265(24):14444-9. PubMed ID: 2387864
[TBL] [Abstract][Full Text] [Related]
40. Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b.
Soames CJ; Day AJ; Sim RB
Biochem J; 1996 Apr; 315 ( Pt 2)(Pt 2):523-31. PubMed ID: 8615824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
